Back To: Home

Our 2020 Media Kit is now available
Your gateway to the latest oncology news, trends and resources
Inside this issue:
September 2020
Are cancer stem cells a better oncology target?...
by Randall C Willis
September 2020
Amgen executive forecasts multispecific drugs as the next key movement...
by Kristen Smith
September 2020
Immunomedics shares strong data for Trodelvy in triple-negative breast cancer...
by Kelsey Kaustinen
July/August 2020
ROME Therapeutics launches with a focus on repeatome-based drug discovery...
by Kelsey Kaustinen
Patent Docs:
U.S. Trade Representative Releases 2020 Special 301 Report
Once again this year, the report highlights compulsory licensing as a particular concern with regard to pharmaceuticals and medical devices. To read a commentary by Kevin Noonan of the "Patent Docs" blog, click here.

Editor's Focus:
September 2020
Innovative lab software automates scheduling, hit-picking and liquid transfer to boost walkaway time.. [ more ]
by Darren Arney of Biosero

September 2020
More meetings are going virtual, and that may very well be a good thing even after COVID is no longer a pandemic.. [ more ]
by Peter T. Kissinger

September 2020
Market research suggests that neurology-related pharma and biotech R&D is going to be dominated by Alzheimer's disease for some time.. [ more ]
by Jeffrey Bouley

1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by Offenberger & White.